Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
Sheng Chang, Xiao‐Kang Li
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

IgA nephropathy
Eleni Stamellou, Claudia Seikrit, Sydney C.W. Tang, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 64
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies
Chee Kay Cheung, Jonathan Barratt, Adrian Liew, et al.
Frontiers in Nephrology (2024) Vol. 3
Open Access | Times Cited: 17
Pathogenesis of IgA Vasculitis: An Up-To-Date Review
Yan Song, Xiaohan Huang, Guizhen Yu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 90
Immune abnormalities in IgA nephropathy
Micaela Gentile, Luis Sanchez-Russo, Leonardo V. Riella, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 7, pp. 1059-1070
Open Access | Times Cited: 30
Immunology of Kidney Disease
Orestes Foresto‐Neto, Luísa Menezes-Silva, Jefferson Antônio Leite, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 207-233
Closed Access | Times Cited: 7
Oral bacteria induce IgA autoantibodies against a mesangial protein in IgA nephropathy model mice
Mizuki Higashiyama, Kei Haniuda, Yoshihito Nihei, et al.
Life Science Alliance (2024) Vol. 7, Iss. 4, pp. e202402588-e202402588
Open Access | Times Cited: 5
TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases
Philip Chiu‐Tsun Tang, Alex Chan, Cai-Bin Zhang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 38
New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
Dita Maixnerová, Delphine El Mehdi, Dana V. Rizk, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2810-2810
Open Access | Times Cited: 25
Identifying functional subtypes of IgA nephropathy based on three machine learning algorithms and WGCNA
Hongbiao Ren, Wenhua Lv, Zhenwei Shang, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway
Honglian Li, Ruirui Lu, Yu Pang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 36
Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases
Paulina Mertowska, Sebastian Mertowski, Iwona Smarz-Widelska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 647-647
Open Access | Times Cited: 19
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
Pedro Alves Soares Vaz de Castro, Arthur Aguiar Amaral, Mariana Godinho Almeida, et al.
Journal of Nephrology (2024)
Open Access | Times Cited: 3
Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes
Wadih Issa, Rachel Njeim, Arianna Carrazco, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1157-1157
Open Access | Times Cited: 3
A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy
Miki Takahara, Toshihiro Nagato, Yui Nozaki, et al.
Cellular Immunology (2019) Vol. 341, pp. 103925-103925
Open Access | Times Cited: 32
Recent advances of gut microbiota in chronic kidney disease patients
Ying‐Yong Zhao
Exploration of Medicine (2022), pp. 260-274
Open Access | Times Cited: 17
Downregulation of miR‑214-3p attenuates mesangial hypercellularity by targeting PTEN‑mediated JNK/c-Jun signaling in IgA nephropathy
Yan Li, Ming Xia, Liang Peng, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 13, pp. 3343-3355
Open Access | Times Cited: 21
Emerging role of monoclonal antibodies in the treatment of IgA nephropathy
Dita Maixnerová, Vladimı́r Tesař
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 5, pp. 419-427
Closed Access | Times Cited: 8
Successful pregnancy in a patient with IgA nephropathy treated with telitacicept: a case report
Xinru Du, Tian Geng, Xuehong Lu
BMC Pregnancy and Childbirth (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case-control study
Meng Wang, Jianfei Ma, Yao Li, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 10
Open Access | Times Cited: 2
Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
Mateus Justi Luvizotto, Luísa Menezes-Silva, Viktória Woronik, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
The Human Virome and Its Crosslink with Glomerulonephritis and IgA Nephropathy
Fabio Sallustio, Angela Picerno, Francesca Montenegro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3897-3897
Open Access | Times Cited: 7
Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis
Xiaohui Li, Mengru Zeng, Jialu Liu, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation
Mayuko Kawabe, Izumi Yamamoto, Takafumi Yamakawa, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 18
Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation
Mayuko Kawabe, Izumi Yamamoto
˜The œNephron journals/Nephron journals (2023) Vol. 147, Iss. Suppl. 1, pp. 9-13
Closed Access | Times Cited: 6
The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy
Zhao Zhang, Guorong Zhang, Meng Guo, et al.
Pathogens (2021) Vol. 10, Iss. 7, pp. 881-881
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top